[ad_1]
The coronavirus vaccine developed jointly by US-based BioNTech and Pfizer was announced to have achieved 90 percent success. Speaking to The Guardian newspaper published in England, Şahin stated that he was confident that the Covid-19 vaccine they developed would “crush the head of the virus” and end the epidemic that gripped the world in 2020.
In a press release on Monday, Pfizer and BioNTech stated that in phase 3 of the vaccine trials, 90 percent of the volunteers avoided developing the disease, and this rate was better than expected. However, the question of whether the vaccine is effective in asymptomatic infections has not been answered, as the results of the trial have not yet been explained in detail.
ŞAHİN: WE KNOW THAT THE VACCINE WILL BEAT THIS VIRUS
Saying he is optimistic on this issue, Şahin said: “If the question is whether we can stop the pandemic with this vaccine, then my answer is yes, because protection even against symptomatic infections will have a great effect.”
Stating that they are not sure whether the vaccine will trigger a strong enough response in the immune system until the results of the test studies were announced last Monday, Şahin said: “We now know that the vaccine will defeat this virus.”
“IT REACHES THE VIRUS ON THE HEAD AND REMOVES IT”
According to the news on BBC Turkish, Şahin, 55, claimed that he believes the vaccine will also prevent transmission of the virus, although it has not yet been officially tested due to the results of the vaccine they developed.
Claiming that the vaccine attacks the virus “in more ways than one,” Şahin said: “It prevents Covid-19 from entering our cells. But even if the virus has somehow entered, it attacks the cells in the head of the virus. and it eliminates it. We have trained the immune system very well to carry out these two defensive actions. Now we know that the virus cannot defend itself against these mechanisms, “he said.
Stating that some important questions about the vaccine’s effectiveness can be answered in the coming weeks and months, Şahin noted that answering the question of whether it can stop asymptomatic infections can take up to a year.
[ad_2]